| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |